Bio2Bedside is a founder-focused media and intelligence platform that transforms in-depth scientific interviews into investor-ready profiles and exclusive insights for the next generation of biotech.
exclusive insights
Featured biotech:
turning authentic stories into exclusive data
- About Us
Our Mision
Bio2Bedside helps early-stage biotech founders tell their story, showcase their science, and build meaningful connections with investors, partners, and the broader community.
Our Vision
We aim to build a dynamic, data-rich ecosystem that connects credible biotech founders with the investors, partners, and audiences who move the industry forward.
- Featured Biotech
who we've talked to
From platform startups to modality pioneers, these early-stage companies are solving big problems with bold science. Each one has been featured live on Bio2Bedside.
Turning Solid Tumors into Soft Tumors with Bacteria
Gene Therapy for Rare Diseases
Mutli-Genic CAR-T Cells for Solid Tumors
Cell-Mediated Drug Delivery
Small Molecule Therapeutics for Cancer
bio2bedside
- Meet the hosts
Part science, part strategy, part live conversation – our work sits at the intersection of biotech and media.
Meet the Bio2Bedside Team
Ben McLeod
Co-Founder
Jeff Martin, PhD
Co-Founder
Jeff Martin, PhD
Co-Founder Bio2Bedside
- Our Community
We Are Founders. We Are Scientists. We Are Investors.
Bio2Bedside isn’t just a live show – it’s a space to learn, connect, and grow with the future of biotech.
bio2bedside
- Our Insights
critical analysis of industry trends & recent news
Bio2Bedside Featured Biotech Neobe Therapeutics Neobe is a UK-based biotech engineering tumor-targeting bacterial therapies to…
Bio2Bedside Featured Biotech KiraGen Bio KiraGen Bio is developing multi-plex gene-edited CAR-T cell therapies for…
- FAQs
Frequently Asked Questions
What is Bio2Bedside?
Bio2Bedside is a live interview show and media platform where early-stage biotech companies share their science, tell their story, and get discovered by the people who matter—investors, operators, and other founders.
Who is this for?
Founders, scientists, investors, and anyone building or backing early biotech. Whether you're fundraising, scouting deals, or just want to stay sharp—this is for you.
How do I get featured?
Apply through our website. We review submissions based on scientific merit, team experience, and strategic fit. If selected, we’ll invite you on the show and build your custom profile.
Is there a cost to be featured?
Yes, pricing starts at $3,500 and scales with deliverables. To be clear, this is not "pay-to-play". The associated cost is used to fund the production of the show and support the creators.
Is this just another biotech "podcast"?
Not even close. This is real-time, founder-led biotech coverage - with science, strategy, and story all in one place. Think of it as biotech’s media layer, not just a podcast.
What’s included in a company profile?
Each profile includes a full interview, highlight clips, founder bios, a tech overview, and visibility across our community. It’s your story, built to last and made to be shared.
Where can I watch the episodes?
Episodes stream live on LinkedIn and YouTube. Replays, short clips, and full company profiles are available anytime on the company or insights pages.
Can I refer a company?
Absolutely. We love referrals from VCs, operators, or fellow founders. Send us an intro or use the referral form on our site.